Valentina Audrito

13PUBLICATIONS
45CO-AUTHORS
NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2026
Correction: Audrito et al. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers 2020, 12, 3855.

|Oct 16, 2025
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets".

Laura Conti, Valentina Audrito

|Sep 04, 2024
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype.

Mariadomenica Lupi, Daniele Avanzato, Stefano Confalonieri

|Jan 11, 2024
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?

Chiara Cossu, Antonino Di Lorenzo, Irene Fiorilla

|Aug 26, 2023
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma.

Irene Fiorilla, Simona Martinotti, Alberto Maria Todesco

|Apr 13, 2023
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.

Sara Boumya, Silvia Fallarini, Sonia Siragusa

Pageof 3

Frequent Collaborators

4 joint publications

Chiara Riganti

4 joint publications

Silvia Deaglio

3 joint publications

Elisa Pellegrino

3 joint publications

Roberto Piva